-
Breaking Regulatory News: FDA Panel Unexpectedly Recommends Approval for Parkinson's Disease Neurogenic Orthostatic Hypotension Drug
February 24, 2012
… on Northera investigating its potential to treat gait, sleep and cognitive disorders in Parkinson’s disease under …
-
Study Finds Depression Linked to Increased Risk of Parkinson’s
October 8, 2013
… with known risk factors: loss of the sense of smell, REM sleep behavior disorder or mutation of either the LRRK2 or …
-
Neupro Patch Approved for Use in Canada
April 2, 2013
… potential benefit to taking Neupro surrounds getting enough sleep. Health Canada also approved the patch to treat …
-
MJFF Survey Results: People with Parkinson’s Share Experiences with Cannabis
January 21, 2022
… reported small improvements in pain, anxiety, agitation or sleep. The most common side effects include dry mouth, … the disease. And, as in this study, I’ve seen benefits for sleep, pain, anxiety and, sometimes, for motor symptoms. … to help with symptoms as reported in this survey: anxiety, sleep and pain. I encourage people to let their movement …
-
Sinemet CR Discontinued but Other Options Available
July 18, 2019
… fewer doses of medication per day. For others, it’s better sleep because symptoms are controlled overnight. Merck, the …
-
Ongentys (opicapone)
… may include dyskinesia (involuntary movement), difficulty sleeping, sleepiness, abnormal dreams, dizziness, headache, low blood …